| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
3 companies
Hecht Beth is a See Remarks at Xeris Biopharma Holdings, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $7.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 16,667 | $6.23 | $103,805.41 | -1.4% | - | - | |
| Feb 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 16,667 | $7.45 | $124,147.48 | -1.3% | -14.7% | - | |
| Jan 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 16,667 | $7.43 | $123,775.81 | -1.3% | -17.8% | - | |
| Dec 1, 2025 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 16,667 | $7.01 | $116,780.67 | -1.2% | -13.5% | - | |
| Nov 11, 2025 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 16,667 | $7.40 | $123,295.80 | -1.2% | -6.5% | - | |
| Mar 20, 2025 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 40,000 | $5.43 | $217,244.00 | -2.9% | -15.7% | +0.2% |